Ito Makoto, Mizumoto Yusei, Murakami Yasushi, Nakano Satsuki, Takagi Norio
Department of Hematology, Tokoname City Hospital, Tokoname, JPN.
Department of Hematology and Oncology, Graduate School of Medicine, Nagoya University, Nagoya, JPN.
Cureus. 2025 Mar 18;17(3):e80802. doi: 10.7759/cureus.80802. eCollection 2025 Mar.
Lymphomatoid granulomatosis (LYG) is a rare Epstein-Barr virus-driven B-cell lymphoproliferative disease that often progresses to high-grade lymphoma. We describe a case of high-grade LYG causing Pancoast syndrome, diagnosed via transbronchial biopsy after a failed incisional biopsy. Complete remission was achieved with R-CHOP (rituximab, doxorubicin, cyclophosphamide, vincristine, and prednisolone), but 2.5 years later, the patient developed lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia (LPL/WM). Despite bendamustine-rituximab improving LPL/WM, LYG recurred, underscoring its treatment challenges. This case highlights LYG's diagnostic complexity, its potential link with other hematologic malignancies, and therapeutic limitations. Further research is needed to elucidate LYG's pathogenesis and develop effective treatments for relapsed cases.
淋巴瘤样肉芽肿病(LYG)是一种罕见的由爱泼斯坦-巴尔病毒驱动的B细胞淋巴增殖性疾病,常进展为高级别淋巴瘤。我们描述了一例导致潘科斯特综合征的高级别LYG病例,在切开活检失败后通过经支气管活检确诊。使用R-CHOP(利妥昔单抗、阿霉素、环磷酰胺、长春新碱和泼尼松龙)实现了完全缓解,但2.5年后,患者发展为淋巴浆细胞淋巴瘤/华氏巨球蛋白血症(LPL/WM)。尽管苯达莫司汀-利妥昔单抗改善了LPL/WM,但LYG复发,凸显了其治疗挑战。该病例突出了LYG的诊断复杂性、其与其他血液系统恶性肿瘤的潜在联系以及治疗局限性。需要进一步研究以阐明LYG的发病机制并开发针对复发病例的有效治疗方法。